(Q33400705)

26 July 2017

title

Renal transplantation under prophylactic eculizumab in atypical hemolytic uremic syndrome with CFH/CFHR1 hybrid protein (English)

1 reference

atypical hemolytic uremic syndrome

26 July 2017

main subject

1 reference

O Boyer

5

0 references

author name string

S Krid

1

1 reference

26 July 2017

L T Roumenina

2

1 reference

26 July 2017

D Beury

3

1 reference

26 July 2017

M Charbit

4

1 reference

26 July 2017

V Frémeaux-Bacchi

6

1 reference

26 July 2017

P Niaudet

7

1 reference

26 July 2017

language of work or name

English

0 references

publication date

11 April 2012

1 reference

American Journal of Transplantation

26 July 2017

published in

1 reference

26 July 2017

volume

12

1 reference

26 July 2017

issue

7

1 reference

26 July 2017

page(s)

1938-1944

1 reference

Complement and the atypical hemolytic uremic syndrome in children.

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04051.X

Alternative complement pathway assessment in patients with atypical HUS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04051.X

Atypical haemolytic uraemic syndrome associated with a hybrid complement gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04051.X

Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04051.X

New insights into postrenal transplant hemolytic uremic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04051.X

Liver-kidney transplantation to cure atypical hemolytic uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04051.X

Eculizumab for congenital atypical hemolytic-uremic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04051.X

Pre-emptive eculizumab and plasmapheresis for renal transplant in atypical hemolytic uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04051.X

Prophylactic eculizumab after renal transplantation in atypical hemolytic-uremic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04051.X

Deletion of complement factor H-related genes CFHR1 and CFHR3 is associated with atypical hemolytic uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04051.X

Dual interaction of factor H with C3d and glycosaminoglycans in host-nonhost discrimination by complement

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04051.X

Functional analysis in serum from atypical Hemolytic Uremic Syndrome patients reveals impaired protection of host cells associated with mutations in factor H.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04051.X

Neurological involvement in a child with atypical hemolytic uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04051.X

A novel deletion in the RCA gene cluster causes atypical hemolytic uremic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04051.X

Structural and functional characterization of factor H mutations associated with atypical hemolytic uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04051.X

De novo gene conversion in the RCA gene cluster (1q32) causes mutations in complement factor H associated with atypical hemolytic uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04051.X

Structural and functional characterization of the product of disease-related factor H gene conversion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04051.X

Prophylactic eculizumab prior to kidney transplantation for atypical hemolytic uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04051.X

The use of antibody to complement protein C5 for salvage treatment of severe antibody-mediated rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04051.X

Efficacy of eculizumab in the treatment of recurrent atypical hemolytic-uremic syndrome after renal transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04051.X

Maintenance of kidney function following treatment with eculizumab and discontinuation of plasma exchange after a third kidney transplant for atypical hemolytic uremic syndrome associated with a CFH mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04051.X

Eculizumab induces long-term remission in recurrent post-transplant HUS associated with C3 gene mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04051.X

Eculizumab for Atypical Hemolytic–Uremic Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04051.X

10.1111/J.1600-6143.2012.04051.X

21 January 2018

Identifiers

DOI

1 reference

26 July 2017

1 reference